2025
Unraveling the role of viral interference in disrupting biennial RSV epidemics in northern Stockholm
Li K, Hamrin J, Nilsson A, Weinberger D, Pitzer V. Unraveling the role of viral interference in disrupting biennial RSV epidemics in northern Stockholm. Nature Communications 2025, 16: 8137. PMID: 40885786, PMCID: PMC12398580, DOI: 10.1038/s41467-025-63654-1.Peer-Reviewed Original ResearchConceptsRespiratory syncytial virusRespiratory syncytial virus activityViral interferenceH1N1 pandemic influenza virusPandemic H1N1 virusPandemic influenza virusNorthern StockholmBiennial patternH1N1 virusInfluenza virusIn vivo studiesRespiratory virusesSyncytial virusInfluenza pandemicRSV epidemicsBirth rateInfluenzaPublic health interventionsWinter outbreaksVirusAdmission dataH1N1InfantsOlder adultsHealth interventionsExploring RSV Transmission Patterns in Different Age Groups in the United States
Li K, Pitzer V, Weinberger D. Exploring RSV Transmission Patterns in Different Age Groups in the United States. The Journal Of Infectious Diseases 2025, 232: 700-708. PMID: 40308004, PMCID: PMC12455310, DOI: 10.1093/infdis/jiaf230.Peer-Reviewed Original ResearchThe Role of Viral Interference in Shaping RSV Epidemics Following the 2009 H1N1 Influenza Pandemic
Li K, Thindwa D, Weinberger D, Pitzer V. The Role of Viral Interference in Shaping RSV Epidemics Following the 2009 H1N1 Influenza Pandemic. Influenza And Other Respiratory Viruses 2025, 19: e70111. PMID: 40275825, PMCID: PMC12022500, DOI: 10.1111/irv.70111.Peer-Reviewed Original ResearchConceptsRespiratory syncytial virusRespiratory syncytial virus activityRespiratory syncytial virus epidemicsInfluenza pandemicViral interferenceLaboratory-confirmed RSV casesRSV epidemicsDecreased RSV infectionH1N1 influenza pandemicRSV infectionRSV seasonRSV casesSyncytial virusPandemic influenzaInfluenzaRSV activityCo-InfectionSurveillance dataEpidemicUnited StatesUS regionsH1N1Relating In Vivo Respiratory Syncytial Virus Infection Kinetics to Host Infectiousness in Different Age Groups
Li K, Bont L, Weinberger D, Pitzer V. Relating In Vivo Respiratory Syncytial Virus Infection Kinetics to Host Infectiousness in Different Age Groups. The Journal Of Infectious Diseases 2025, 232: 691-699. PMID: 40085821, DOI: 10.1093/infdis/jiaf138.Peer-Reviewed Original ResearchRespiratory syncytial virusViral kineticsAge groupsHigher peak viral loadRespiratory syncytial virus infectionPeak viral loadRespiratory syncytial virus transmissionHousehold transmission studyAge-specific considerationsViral loadSyncytial virusPediatric populationViral infectionPublic health concernSecondary attack rateProcess of viral infectionDecline in Community-Acquired Alveolar Pneumonia Positive for Respiratory Syncytial Virus in Hospitalized Children Following Implementation of Pneumococcal Conjugate Vaccine (PCV) in Israel
Dagan R, van der Beek B, Grupel T, Greenberg D, Keren-Naus A, Ben-Shimol S, Weinberger D. Decline in Community-Acquired Alveolar Pneumonia Positive for Respiratory Syncytial Virus in Hospitalized Children Following Implementation of Pneumococcal Conjugate Vaccine (PCV) in Israel. Clinical Infectious Diseases 2025, ciaf102. PMID: 40052957, DOI: 10.1093/cid/ciaf102.Peer-Reviewed Original ResearchPneumococcal conjugate vaccineImpact of pneumococcal conjugate vaccinesConjugate vaccineCommunity-acquired alveolar pneumoniaPneumococcal conjugate vaccine implementationImplementation of pneumococcal conjugate vaccinesRespiratory syncytial virusAnnual hospitalization rateCommunity-acquiredAlveolar pneumoniaSyncytial virusPCV13 implementationAnnual incidenceYoung childrenHospitalization ratesIncidenceRSVMonthsVaccineChildrenEpisodesRegression modelsSynergistic rolePCV13Binomial regression modelsEstimated Effectiveness of Nirsevimab Against Respiratory Syncytial Virus
Xu H, Aparicio C, Wats A, Araujo B, Pitzer V, Warren J, Shapiro E, Niccolai L, Weinberger D, Oliveira C. Estimated Effectiveness of Nirsevimab Against Respiratory Syncytial Virus. JAMA Network Open 2025, 8: e250380. PMID: 40063022, PMCID: PMC11894488, DOI: 10.1001/jamanetworkopen.2025.0380.Peer-Reviewed Original ResearchConceptsRSV-positive casesCase-control studyRSV infectionLRTI-associated hospitalizationsWeeks postimmunizationLong-acting monoclonal antibodiesTest-negative case-control studyClinical settingRespiratory syncytial virusMultivariate logistic regressionYale New Haven Health SystemRSV diseaseEmergency department dataState immunization registryRSV seasonSyncytial virusNirsevimabPolymerase chain reactionClinical trialsLRTIInfantsPotential confoundersMonoclonal antibodiesBroader outcomesDisease severity
2024
Interactions between respiratory syncytial virus and Streptococcus pneumoniae in the pathogenesis of childhood respiratory infections: a systematic review
Besteman S, Bogaert D, Bont L, Mejias A, Ramilo O, Weinberger D, Dagan R. Interactions between respiratory syncytial virus and Streptococcus pneumoniae in the pathogenesis of childhood respiratory infections: a systematic review. The Lancet Respiratory Medicine 2024, 12: 915-932. PMID: 38991585, DOI: 10.1016/s2213-2600(24)00148-6.Peer-Reviewed Original ResearchRespiratory syncytial virusChildhood respiratory infectionsRespiratory infectionsSyncytial virusStreptococcus pneumoniaeRespiratory syncytial virus vaccineLower respiratory tract infectionsRespiratory tract infectionsSystematic reviewGlobal health burdenYears of ageRSV hospitalisationTract infectionsPneumococcal vaccineSevere diseaseGlobal morbidityEpidemiological associationMonoclonal antibodiesPathogen-pathogen interactionsPneumococciInfectionHealth burdenPathogenesisHost modulationApproaches to disease preventionWorkshop on the design and use of clinical trials with multiple endpoints, with a focus on prevention of RSV
Prunas O, Willemsen J, Warren J, Bont L, Schwartz J, Atwell J, Begier E, Dean N, Hirsch I, Karron R, Klugman K, Kramer R, Leidman E, Link-Gelles R, Nair H, Panozzo C, Pelfrene E, Simões E, Smith P, Srikantiah P, Sundaram M, Thindwa D, Vaughn D, Wilson E, Zar H, Pitzer V, Weinberger D. Workshop on the design and use of clinical trials with multiple endpoints, with a focus on prevention of RSV. Vaccine X 2024, 19: 100509. PMID: 40874090, PMCID: PMC11913657, DOI: 10.1016/j.jvacx.2024.100509.Peer-Reviewed Original ResearchRespiratory syncytial virusRandomized Controlled TrialsPreventive therapyPrevention of respiratory syncytial virusTrial designSuccess of randomized controlled trialsVaccine trial designDesign randomized controlled trialClinical trial designEstimates of vaccine efficacyPrimary endpointSyncytial virusClinical trialsVaccine efficacyControlled TrialsMeta-regression modelsSelection of primary endpointsEndpointSequential trial designTherapyMultiple endpoints
2023
The full value of immunisation against respiratory syncytial virus for infants younger than 1 year: effects beyond prevention of acute respiratory illness
Feikin D, Karron R, Saha S, Sparrow E, Srikantiah P, Weinberger D, Zar H. The full value of immunisation against respiratory syncytial virus for infants younger than 1 year: effects beyond prevention of acute respiratory illness. The Lancet Infectious Diseases 2023, 24: e318-e327. PMID: 38000374, DOI: 10.1016/s1473-3099(23)00568-6.Peer-Reviewed Original ResearchLower respiratory tract infectionsRespiratory syncytial virusRSV diseaseRespiratory illnessSyncytial virusRespiratory diseaseAcute lower respiratory tract infectionPrevention of RSVAcute respiratory illnessRespiratory tract infectionsImportant public health benefitsInappropriate antibiotic useSevere respiratory illnessCause infant mortalityCost-effective interventionPublic health benefitsHealth care systemMaternal vaccinesRecurrent hospitalisationsRSV preventionSecondary pneumoniaTract infectionsMiddle-income countriesLung healthAntibiotic use
2022
Saliva as an alternative to nasopharyngeal swabs for detection of respiratory syncytial virus (RSV) in children
Langedijk A, Allicock O, Van Wijk M, Yolda-Carr D, Weinberger D, Wyllie A, Bont L. Saliva as an alternative to nasopharyngeal swabs for detection of respiratory syncytial virus (RSV) in children. 2022, 4519. DOI: 10.1183/13993003.congress-2022.4519.Peer-Reviewed Original Research
2021
Estimation of the Timing and Intensity of Reemergence of Respiratory Syncytial Virus Following the COVID-19 Pandemic in the US
Zheng Z, Pitzer VE, Shapiro ED, Bont LJ, Weinberger DM. Estimation of the Timing and Intensity of Reemergence of Respiratory Syncytial Virus Following the COVID-19 Pandemic in the US. JAMA Network Open 2021, 4: e2141779. PMID: 34913973, PMCID: PMC8678706, DOI: 10.1001/jamanetworkopen.2021.41779.Peer-Reviewed Original ResearchConceptsRespiratory syncytial virusRSV epidemicsMathematical modelRSV hospitalizationRSV seasonSyncytial virusSummer epidemicsRSV lower respiratory tract infectionLower respiratory tract infectionsCOVID-19 pandemicLarge RSV outbreaksMaternal-derived immunityRespiratory tract infectionsChildren 1 yearYears of ageSARS-CoV-2Simulation modeling studyProphylaxis administrationRSV circulationRSV infectionRSV outbreaksSecondary outcomesTract infectionsPrimary outcomeLeading causeCommunity factors associated with local epidemic timing of respiratory syncytial virus: A spatiotemporal modeling study
Zheng Z, Pitzer VE, Warren JL, Weinberger DM. Community factors associated with local epidemic timing of respiratory syncytial virus: A spatiotemporal modeling study. Science Advances 2021, 7: eabd6421. PMID: 34162556, PMCID: PMC8221622, DOI: 10.1126/sciadv.abd6421.Peer-Reviewed Original ResearchRespiratory syncytial virusEpidemic timingSyncytial virusRSV epidemicsBayesian meta-regression modelTiming of deliveryMaternal vaccinesMeta-regression modelsHospitalization dataLarge burdenEarly epidemicLarger household sizeYoung childrenTransmission dynamicsZip code levelEpidemicCommunity factorsEpidemic spreadFuture studiesVirusProphylaxisMorbidityVaccineFactors
2015
Association between Respiratory Syncytial Virus Activity and Pneumococcal Disease in Infants: A Time Series Analysis of US Hospitalization Data
Weinberger DM, Klugman KP, Steiner CA, Simonsen L, Viboud C. Association between Respiratory Syncytial Virus Activity and Pneumococcal Disease in Infants: A Time Series Analysis of US Hospitalization Data. PLOS Medicine 2015, 12: e1001776. PMID: 25562317, PMCID: PMC4285401, DOI: 10.1371/journal.pmed.1001776.Peer-Reviewed Original ResearchConceptsRespiratory syncytial virusPneumococcal pneumoniaRate of hospitalizationPneumococcal diseaseHospitalization dataSeven-valent pneumococcal conjugate vaccineBacterial infectionsRespiratory syncytial virus activityLaboratory-confirmed dataPneumococcal pneumonia hospitalizationsPneumococcal conjugate vaccineIntroduction of PCV7Secondary bacterial infectionState Inpatient DatabasesPoisson regression modelsRSV hospitalizationPCV7 introductionPneumonia hospitalizationsConjugate vaccineInpatient DatabaseSyncytial virusPneumococcal septicemiaPneumonia casesEpidemic timingHospitalization
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply